Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retigabine adjunctive therapy in partial-onset seizures (RESTORE 2)
NCT00235755Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of retigabine in epilepsy, sponsored by GSK. Started Dec 2005; status: completed.
02
Drugs
retigabine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00235755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235755.